NVO261127C00050000
NVO Nov 27 2026 50.00 Call
optionOPRA
EODOct 20, 2026
0.10USD-37.500%(-0.06)19Vol51OI
Loading…
Underlying
Underlying Price
$38.90
Type
Call
Strike
50
Expiration
Nov 27, 2026
DTE
34d
Moneyness
OTM
Intrinsic
$0.00
NVO 50 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | -1d | $0.19 | +1800.00% | 200 | 330 |
| Oct 30, 2026 | 6d | $0.01 | +0.00% | 3 | 396 |
| Nov 6, 2026 | 13d | $0.05 | +0.00% | 6 | 471 |
| Nov 13, 2026 | 20d | $0.06 | -25.00% | 2 | 3 |
| Nov 20, 2026 | 27d | $0.08 | +33.33% | 73 | 9,325 |
| Nov 27, 2026 | 34d | $0.10 | -37.50% | 19 | 51 |
| Dec 18, 2026 | 55d | $0.21 | +10.53% | 89 | 26,024 |
| Jan 15, 2027 | 83d | $0.38 | +5.56% | 211 | 20,329 |
| Mar 19, 2027 | 146d | $1.08 | +6.93% | 55 | 8,521 |
| Jun 17, 2027 | 236d | $1.84 | +6.98% | 79 | 7,513 |
| Sep 17, 2027 | 328d | $2.57 | -1.91% | 5 | 351 |
| Dec 17, 2027 | 419d | $3.42 | -0.87% | 105 | 5,134 |
| Jan 21, 2028 | 454d | $3.70 | +3.93% | 224 | 10,969 |
| Jun 16, 2028 | 601d | $4.69 | +3.08% | 3 | 329 |
| Dec 15, 2028 | 783d | $5.80 | -1.19% | 6 | 1,730 |
| Jan 19, 2029 | 818d | $6.18 | -4.19% | 4 | 866 |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.